Loading...

Mangoceuticals, Inc.

MGRX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$1.66
$-0.07(-4.05%)

Mangoceuticals, Inc. (MGRX) Stock Overview

Explore Mangoceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 58.5/100

Key Financials

Market Cap17.5M
P/E Ratio-1.19
EPS (TTM)$-3.54
ROE-0.85%
Fundamental Analysis

AI Price Forecasts

1 Week$2.25
1 Month$1.15
3 Months$4.92
1 Year Target$0.43

MGRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mangoceuticals, Inc. (MGRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.43.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.19 and a market capitalization of 17.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-10.29%
5-Day Change
-21.50%
1-Month Change
-68.02%
3-Month Change
-41.20%
6-Month Change
-51.54%
Year-to-Date (YTD) Change
-36.95%
1-Year Change
-58.90%
3-Year Change
-97.38%
5-Year Change
-97.38%
All-Time (Max) Change
-97.38%

Contact Information

https://www.mangorx.com
(214) 242-9619
15110 North Dallas Parkway, Dallas, TX, 75248

Company Facts

3 Employees
IPO DateMar 21, 2023
CountryUS
Actively Trading

Frequently Asked Questions

;